| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.70B | 19.93B | 17.44B | 13.29B | 9.66B | 8.92B |
| Gross Profit | 6.13B | 7.41B | 6.45B | 4.74B | 2.89B | 3.04B |
| EBITDA | 5.77B | 5.35B | 4.85B | 3.61B | 1.72B | 2.32B |
| Net Income | 4.87B | 4.40B | 4.31B | 4.44B | 1.48B | 2.16B |
Balance Sheet | ||||||
| Total Assets | 68.53B | 67.06B | 70.91B | 58.91B | 47.99B | 45.10B |
| Cash, Cash Equivalents and Short-Term Investments | 914.00M | 11.54B | 9.31B | 8.05B | 6.50B | 7.14B |
| Total Debt | 2.73B | 2.73B | 2.73B | 2.73B | 2.73B | 2.72B |
| Total Liabilities | 44.34B | 42.85B | 50.09B | 40.55B | 35.07B | 31.55B |
| Stockholders Equity | 24.19B | 24.21B | 20.82B | 18.35B | 12.91B | 13.55B |
Cash Flow | ||||||
| Free Cash Flow | 5.86B | 6.13B | 6.62B | 5.70B | 3.76B | 3.39B |
| Operating Cash Flow | 5.90B | 6.17B | 6.67B | 5.75B | 3.82B | 3.43B |
| Investing Cash Flow | -3.67B | -4.04B | -4.46B | -5.47B | -3.10B | -2.14B |
| Financing Cash Flow | -2.48B | -1.89B | -1.93B | -69.00M | -706.00M | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $37.50B | 10.99 | 22.01% | 1.55% | 6.90% | 41.67% | |
73 Outperform | $33.65B | ― | 21.07% | ― | 8.66% | 32.96% | |
73 Outperform | $21.80B | 11.69 | 13.53% | 3.44% | -1.98% | 48.93% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $9.73B | 7.37 | 16.72% | 6.98% | 13.12% | 33.51% | |
62 Neutral | $40.13B | 15.62 | 7.50% | 2.02% | -19.92% | 7.41% | |
50 Neutral | $11.88B | 15.82 | -152.32% | 2.15% | -16.14% | -224.34% |